Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Data Management & Analysis Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma


Funder NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization Boston Children'S Hospital
Country United States
Start Date Mar 10, 2022
End Date Feb 28, 2027
Duration 1,816 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10589803
Grant Description

PROJECT SUMMARY: IDEAL Data Management Core (DMC) The overarching goal of the proposed immune development in early life (IDEAL) project is to employ systems biology to characterize childhood immune trajectories in order to define endotypes of key clinical outcomes such as vaccine responsiveness, respiratory infection and asthma. In support of this effort, the Data Management

Core (DMC) will establish and maintain a cloud-based discovery environment, consisting of data storage and computational tools to perform integrative systems analyses of clinical data, lab sample management, and high dimensional assay results. The DMC will facilitate collaborations between the IDEAL Projects and Cores

including data sharing, submission to public repositories, and engagement with the external research community. The broad goals of the DMC are reliable data capture and retention, ongoing quality assurance (QA), and access/computational resources for integrative analyses. We articulate these goals through three Specific Aims,

including establishment of digital infrastructure for data capture, management, and analysis; rigorous quality control (QC) and QA; and biostatistical and bioinformatics expertise for analysis. Our data management architecture is designed on the basis of improved institutional capabilities for reliable

cloud-based clinical data management, experimental assay QC/QA, and analytic support. We have worked closely with the BCH Research Computing Department to implement a system for IDEAL collaborators that will combine security and reliability with accessibility and state-of-the-art computational tools and resources. Our

approach offers many advantages over more traditional server-based architecture, not the least of which is a fruitful collaborative computing environment for integrative analyses and scientific discovery. Any scientific endeavor of this scope and scale requires robust data management plans, infrastructure, and

operations. Indeed, there can be no practical integration of data without an environment to link these data across platforms. The DMC’s integrative function is necessary to leverage the distinct strengths of the IDEAL projects and cores into scientific synergies. We expect our integrated discovery environment will augment the scientific

value and productivity of the overall IDEAL study. The DMC will enable us to discover endotype-specific molecules and pathways, that may serve as prognostic and/or actionable biomarkers to predict clinical outcomes and/or that represent targets for interventions that redirect IDEAL towards health.

All Grantees

Boston Children'S Hospital

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant